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Abstract
Germ cell tumours tend to affect young adults and with advanced treatments achieve more than
90% cure rates. Over the years cisplatin has significantly improved the relapse free survival in these
patients, hence forming an essential component of chemotherapy regimes. But, the thrombo-
embolic complications suffered with cisplatin significantly affect the quality of life in these young
patients.
We describe a young adult who suffered a potentially fatal cerebral and pulmonary vascular insult
on completing first cycle of cisplatin-based chemotherapy for a non-seminomatous germ cell
tumour. Venous and arterial thrombo-embolism was the mechanism of injury and was promptly
managed surgically and medically including neuro-rehabilitation.
Introduction
Thrombo-embolism is a known vascular toxicity associ-
ated with germ cell tumours, amongst which VTE (Venous
Thrombo-embolism) continues to share the highest pro-
portion. Amongst thrombotic complications, arterial
thrombosis is a rare complication of chemotherapy for
testicular tumours and especially in those lacking any risk
factors. Herein we describe an unusual and unfortunate
case of NSGCT (Nonseminomatous germ cell tumour)
who suffered an extensive internal carotid artery thrombo-
sis and saddle pulmonary embolism after BEP (Bleomy-
cin, Etoposide, Cisplatin) regime of chemotherapy.
Case
A 36 year old previously fit and healthy non-smoker Cau-
casian male underwent left orchidectomy for a testicular
tumour (Fig. 1) with AFP (alpha fetoprotein) levels of 9.7
IU/ml (reference range [RR] <10 IU/ml) and BHCG (beta
human chorionic gonadotrophin) levels of <1.0 IU/L (RR
< 5.0 IU/L), which turned out to be a T2N0M0 stage 1
embryonal carcinoma with vascular invasion but no local
or distant metatstasis on follow-up CT (computed tomog-
raphy) scan. He was kept under monthly surveillance with
tumour markers, chest x-rays, and 3 monthly CT scans;
wherein a scheduled CT scan revealed an ipsilateral right-
sided common iliac lymph node of 15 mm and 5 mm pul-
monary nodule consistent with both local and distant
metastasis. He was therefore started on BEP regime of
chemotherapy. However on the day of completion of first
cycle of BEP regime he was re-admitted to the emergency
department with complaints of sudden onset right-sided
weakness and agitation. Clinical assessment revealed iso-
lated neurological insult viz. motor power being 1/5 on
the right arm and right leg with a constricted left pupil
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reactive to light and a GCS (Glasgow coma score) of 14 i.e.
E4 V4 M6. Initial blood tests depicted normal haematol-
ogy and biochemistry results with a normal magnesium of
0.89 mmol/L(RR = 0.7-1.0 mmol/L) including a normal
CT brain (Fig. 2). An echocardiogram demonstrated no
thrombus in heart, no atrial/ventricular septal defects, no
patent foramen of ovale and no valvular vegetations. He
was therefore treated for a suspicion of encephalitis sec-
ondary to chemotherapy induced immunosuppression,
until a colour duplex ultrasonography of carotids (Fig. 3)
revealed a dense plug of thrombus in left common carotid
artery completely occluding the flow to external and inter-
nal carotid arteries. An emergency carotid thromboem-
bolectomy was performed and the post-operative CT-
angiogram of the carotids (Fig. 4) and brain (Fig. 5)
revealed a further distal occlusion of the left carotid sys-
tem with no flow and an established non-haemorrhagic
infarct of left middle cerebral artery territory (Fig. 6). The
patient was anticoagulated with heparin for 3 days and
later changed to aspirin. The patient by then was densely
hemiplegic on the right side with expressive and receptive
aphasia and right facial nerve palsy with a non-reactive
left pupil. Following which he underwent extensive
neuro-rehabilitation with slow but consistent improve-
ment in his neurological status.
The overall recovery suffered another insult by an exten-
sive saddle pulmonary embolus for which he was antico-
agulated again, only this time with warfarin. The patient's
neurological state showed signs of improvement in terms
of speech, motor power and sensations on right upper
(power 3/5) and lower limbs (power 5/5). But two
months later he demonstrated seizure activity which on
MRI (magnetic resonance imaging) scan confirmed haem-
orrhagic transformation in the large maturing previous
infarct in left middle cerebral artery territory, which was
effectively controlled by anti-epileptics. He later com-
pleted his second cycle of BEP regime and a surveillance
CT scan showed shrinkage of common iliac lymph node
to only 7 mm and the pulmonary nodule of 4 mm.
Tumour markers were normal and the plan was to con-
tinue with scheduled three monthly CT scans.
Discussion
Cisplatin based chemotherapy as in BEP regime is consid-
ered to be highly effective in GCT, but its associated vas-
cular complications include not only venous but also
arterial thrombosis and/or hemorrhages [1-6] with the
frequency of cerebrovascuar complications being less than
1 in 2000 treated patients [1]. The first reported case of
cerebrovascular event following cisplatin based chemo-
therapy dates back to 1983 [7]. Association of cisplatin
with thrombogenic events relates to the vasospasm caused
by various metabolic and hormonal abnormalities.
Increase in Von-willebrand factor antigen, endothelial
Ultrasonograph of Testis showing the seminomatous tumour  of left testis Figure 1
Ultrasonograph of Testis showing the seminomatous 
tumour of left testis.
Admission CT scan of Brain showing no evidence of Ischaemia or Intracranial bleed Figure 2
Admission CT scan of Brain showing no evidence of Ischaemia or Intracranial bleed.Cases Journal 2009, 2:9082 http://www.casesjournal.com/content/2/1/9082
Page 3 of 5
(page number not for citation purposes)
dysfunction, alterations of clotting cascade, thrombox-
ane-prostacyclin homeostatic disturbances, and stimula-
tion of fibroblasts [1,7-9] add to the propensity of
thrombotic events with cisplatin. Cisplatin is also known
to cause autonomic dysfunction [10] and hypomag-
nesemia, both of which could potentiate the arterial
spasm, as magnesium seems to have an important role in
maintaining the tone of the muscular layer of vessels [11].
Our case suffered thrombosis of the carotid system on the
day of finishing his first cycle of BEP chemotherapy,
although the diagnosis of ischaemic stroke was delayed by
a few hours due to the normal appearance of the immedi-
ate CT scan and hence, thought was directed towards a
possibility of encephalitis secondary to chemotherapy
induced immunosuppression. However the co-relation of
history and clinical findings led to the early discovery of
thrombosis of the carotid system on further investiga-
tions. It is difficult to demonstrate that early institution of
active anticoagulation and emergency thrombo-embolec-
tomy dictated his good neurologic recovery. However
emergency surgery removed the thrombus from the left
carotid system to a fairly good extent and the immediate
active anticoagulation played a significant role to main-
tain the patency of blood-flow to the cerebral circulation.
Pretnar et al [12] described a case with similarities of
ischemia in middle cerebral artery territory secondary to
ICA (internal carotid artery) thrombosis in a post BEP
Diagnostic Colour Doppler Ultrasonograph of Left Carotid system showing the thrombus in Left Internal Carotid Artery Figure 3
Diagnostic Colour Doppler Ultrasonograph of Left Carotid system showing the thrombus in Left Internal 
Carotid Artery.
Post-operative CT- Angiogram showing compromised  Carotid and Cerebral circulation Figure 4
Post-operative CT- Angiogram showing compro-
mised Carotid and Cerebral circulation.
Post-operative Remodeled CT- Angiogram showing compro- mised Carotid and Cerebral circulation Figure 5
Post-operative Remodeled CT- Angiogram showing 
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chemotherapy patient for testicular seminoma. Our
patient differed not only in suffering another fatal insult
i.e. saddle pulmonary embolus, but also that the benefits
of anticoagulation and surgery were well observed in his
recovery.
A retrospective analysis [13] of patients with disseminated
germ cell tumours treated with cisplatin-based chemo-
therapy revealed that probability of relapse-free survival
for complete responders was 83.5%. Functional status of
survivors was extremely promising with 95% returning to
their pre-therapy status and 88% fully employed.
It has been demonstrated that liver metastasis, low mag-
nesium, high dose of corticosteroids pose an additional
risk of thrombo-embolic complications in germ cell
tumour patients receiving chemotherapy [13]. Our
patient was a nonsmoker and had none of the aforemen-
tioned risk factors for thromboembolism.
Conclusion
Our case was unique and unfortunate in suffering from
both an extensive arterial thrombosis and venous embo-
lism a few days apart with no risk factors and a negative
family history and a negative cranial CT on admission.
Since the introduction of cisplatin based chemotherapy in
1970s, patients have benefited from longer disease free
survival and better cure rates for any adult malignancy
[14]. The 5-year progression-free and overall survival rates
for NSGCTs have reached highs of 96% and 94% respec-
tively [15]. Our patient though unfortunate to suffer from
the potentially fatal complications of cisplatin based
chemotherapy achieved its associated benefits.
With our experience from this particular case we cannot
emphasis enough the importance of history and clinical
findings and their mutual co-relation to dictate the diag-
nosis with the subsequent aide of most appropriate set of
investigations. Given the incidence of germ cell tumours
in young patients and the high cure rates, patients stay dis-
ease free for a long time. Therefore prevention and early
recognition of adverse effects of treatment is of para-
mount importance as it dictates the quality of life of these
young patients.
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